Biosimilars in inflammatory bowel disease

被引：2
|
作者：
Moore, Gregory T. [1 ,2 ]
机构：
[1] Monash Hlth, Clayton, Vic, Australia
[2] Monash Univ, Clayton, Vic, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2016年 / 205卷 / 07期
关键词：
D O I：
10.5694/mja16.00775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：294 / 295
页数：2
相关论文
共 50 条
  • [41] Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
    Fiorino, Gionata
    Caprioli, Flavio
    Daperno, Marco
    Mocciaro, Filippo
    Principi, Mariabeatrice
    Viscido, Angelo
    Fantini, Massimo Claudio
    Orlando, Ambrogio
    Papi, Claudio
    Annese, Vito
    Danese, Silvio
    Vecchi, Maurizio
    Rizzello, Fernando
    Armuzzi, Alessandro
    Leone, Salvatore
    Previtali, Enrica
    Aloi, Marina
    Alvisi, Patrizia
    Antonelli, Elisabetta
    Ardizzone, Sandro
    Astegiano, Marco
    Baldoni, Monia
    Beltrami, Marina
    Biancone, Livia
    Bodini, Giorgia
    Buda, Andrea
    Bossa, Fabrizio
    Bracci, Fiammetta
    Calabrese, Emma
    Cappello, Maria
    Castiglione, Fabiana
    Ciacci, Carolina
    Cicala, Michele
    Ciccocioppo, Rachele
    Comberlato, Michele
    Cortelezzi, Claudio Camillo
    Cosintino, Rocco
    Costa, Francesco
    Costantino, Giuseppe
    Cucchiara, Salvatore
    Cuomo, Antonio
    D'Inca, Renata
    Di Paolo, Maria Carla
    Di Sabatino, Antonio
    Di Sario, Antonio
    Frieri, Giuseppe
    Fries, Walter
    Gasbarrini, Antonio
    Geccherle, Andrea
    Gionchetti, Paolo
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (05) : 632 - 639
  • [42] Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
    Argueelles-Arias, Federico
    Hinojosa-del-Val, Joaquin
    Vera-Mendoza, Isabel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (06) : 407 - 407
  • [43] Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
    Zeng, Zhen
    Lin, Hao
    Jiang, Mingshan
    Yuan, Jing
    Li, Xi
    Jia, Yongbin
    Yang, Li
    Zhang, Hu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [44] Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists
    Bokemeyer, Bernd
    Dignass, Axel
    Schreiber, Stefan
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (04): : 369 - 374
  • [45] Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
    Anderson, Emilia
    Waller, Karen
    Tamilarasan, Aravind Gokul
    Lin, Huiyu
    Paramsothy, Sudarshan
    Leong, Rupert W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 819 - 825
  • [46] Biosimilars in inflammatory bowel disease: A review of post-marketing experience
    Simona Deiana
    Tommaso Gabbani
    Vito Annese
    World Journal of Gastroenterology, 2017, (02) : 197 - 203
  • [47] Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
    Najeeb, Hala
    Yasmin, Farah
    Surani, Salim
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (14) : 4327 - 4333
  • [48] Outcomes of multiswitching from original infliximab to biosimilars in patients with inflammatory bowel disease
    Nascimento, C.
    Reves, J.
    Morao, B.
    Frias Gomes, C.
    Gouveia, C.
    Palmela, C.
    Roque Ramos, L.
    Fidalgo, C.
    Cravo, M.
    Gloria, L.
    Torres, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S520 - S521
  • [49] Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease
    Bhat, Shubha
    Limdi, Jimmy K.
    Cross, Raymond K.
    Farraye, Francis A.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (08) : 2513 - 2532
  • [50] Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
    Rawla, Prashanth
    Sunkara, Tagore
    Raj, Jeffrey Pradeep
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 215 - 226
12345